Graft Versus Host Disease: Management Issues in the Intensive Care Unit

被引:0
|
作者
Salhotra, Amandeep [1 ]
Ngo, Dat [2 ]
Kareem, Waasil
机构
[1] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Pharm, Duarte, CA USA
关键词
chronic GVHD; intensive care unit; BOS; STEM-CELL TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; ACUTE RESPIRATORY-FAILURE; CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW TRANSPLANTATION; CD4(+) T-CELLS; BRONCHOALVEOLAR LAVAGE; NONINVASIVE VENTILATION; PULMONARY COMPLICATIONS; SPONTANEOUS PNEUMOTHORAX;
D O I
10.1177/08850666241271431
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Graft versus host disease (GVHD) in acute and chronic forms is a frequent post-transplant complication and seen in 50% of patients in acute and up to 70% cases in chronic GVHD setting. Patients with multiorgan involvement and those who are steroid refractory, frequently present with complications arising from this post-transplant complication. These GVHD patients are frequently managed in the Intensive care unit for treatment of air leaks, effusions, management of hypoxemia due to lung GVHD or infections. Close coordination between hematologists and Pulmonary medicine specialists is critical for timely management of these complications to improve patient outcomes.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Graft-versus-host-disease and Intensive Care Medicine
    Liebregts, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 229 - 229
  • [2] An Exceptional Etiology of a Rare Disease: Pneumatosis Intestinalis in the Intensive Care Unit due to Chronic Graft-Versus-Host Disease
    Caliskan, Taner
    Ozkok, Huseyin
    Kucuk, Murat
    Erdogan, Beril Turan
    Uygun, Vedat
    Savran, Yusuf
    Comert, Bilgin
    TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2021, 19 (04): : 200 - 204
  • [3] Graft-versus-host disease management
    Goker, H.
    Karacan, Y.
    Aksu, S.
    Tekin, F.
    Ozcebe, O. I.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S120 - S121
  • [4] Management of Graft-Versus-Host Disease
    Stoddard, Jerrad M.
    Plair, Tamera
    Jee, Yvonne H.
    PHYSICIAN ASSISTANT CLINICS, 2016, 1 (03) : 419 - +
  • [5] MANAGEMENT OF GRAFT-VERSUS-HOST DISEASE
    WEISDORF, DJ
    TRANSFUSION SCIENCE, 1994, 15 (03): : 231 - 242
  • [6] Graft-versus-host disease management
    Mistrik, M.
    Bojtarova, E.
    Sopko, L.
    Masakova, L.
    Roziakova, L.
    Martinka, J.
    Batorova, A.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (07): : 388 - 396
  • [7] Management of graft-versus-host disease
    Arai, S
    Vogelsang, GB
    BLOOD REVIEWS, 2000, 14 (04) : 190 - 204
  • [8] MANAGEMENT OF GRAFT-VERSUS-HOST DISEASE
    RINGDEN, O
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (01) : 1 - 12
  • [9] Current issues in chronic graft-versus-host disease
    Socie, Gerard
    Ritz, Jerome
    BLOOD, 2014, 124 (03) : 374 - 384
  • [10] Graft-versus-host disease Part II. Management of cutaneous graft-versus-host disease
    Hymes, Sharon R.
    Alousi, Amin M.
    Cowen, Edward W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : 535 - 552